Abstract:
PROBLEM TO BE SOLVED: To provide a new pharmaceutical composition for the manufacture of a medicament for the treatment and/or prevention of bipolar disorders, migraine and chronic and/or neuropathic pain. SOLUTION: The (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide is used for the manufacture of the medicament for treatment of particular diseases. The new pharmaceutical composition comprises the (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide. COPYRIGHT: (C)2008,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a therapeutic agent for at least one disease selected from epilepsy, bipolar disorder and neuropathic pain. SOLUTION: The pharmaceutical composition contains (2S)-2-[(4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl]butanamide or its pharmaceutically permissible salt. COPYRIGHT: (C)2006,JPO&NCIPI
Abstract:
PROBLEM TO BE SOLVED: To improve the conventional method by using (meth)acrylated polyester powders. SOLUTION: The problem is solved by a method of producing a heat resistant raised print on a substrate using a radiation-curable powder composition which is cured by using radiation. The powder composition includes one or more radiation-curable (meth)acrylated polyester powders, and, if required, one or more additives. In the method, a (meth)acrylated polyester powder composition is applied to a wet inked print on a substrate to form the coated print, the coated print is heated to a melting temperature to form a raised-melt, and irradiation is applied to the raised-melt so as to form the heat resistant raised print cured by the radiation on the substrate. COPYRIGHT: (C)2005,JPO&NCIPI
Abstract:
PURPOSE: To provide a novel pharmaceutical compsn. in a form of nanocapsule colloid suspension liquid containing a surfactant dissolved in the liquid and plural nanocapsules having